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Prehypertension Subtype and Ischemic Stroke individuals. We thus assessed the association between PreHT and the risk of ischemic stroke among middle-aged and elderly adults in the community, and estimated the usefulness of stratification by hsCRP level for predicting the risk of ischemic stroke in subjects with PreHT.
Methods
Study participants. The Iwate-KENCO study cohort is a population-based prospective study in Japanese residents of the Ninohe, Kuji, and Miyako districts in the northern part of Iwate prefecture, northeast of Honsyu, Japan. 11, 12 Participants were recruited from a government-regulated multiphasic health checkup. According to annual statistical data for 2003 issued by the Iwate prefecture government, this area had a resident population of 241,057 with 26% over the age of 65 years. In this region, there are nine public hospitals with admission facilities. Participants who suffered from cerebro vascular disease usually had access to only these medical institutes. Of 31,318 (11,003 men) individuals aged ≥18 years who took part in the health checkup program between April 2002 and January 2005, 26,469 (9,161 men) individuals consented to participate in this cohort study (85%). After exclusion of participants with previous myocardial infarction (n = 119), previous stroke (n = 872), or missing data (n = 1,456) at baseline, 22,676 subjects (7,666 men and 15,010 women) aged 40-80 years were analyzed for the study.
Follow-up. Diagnosis of stroke was based on the criteria established for the Monitoring System for Cardiovascular Disease commissioned by the Ministry of Health and Welfare. 13 These criteria correspond with those published by the World Health Organization 14 and stroke was defined as the sudden onset of neurological symptoms. Stroke was classified as either ischemic or hemorrhagic based on brain imaging including computed tomography or magnetic resonance imaging. Hospitalized patients with newly diagnosed stroke were registered from April 2002 to August 2007. Patients with transient ischemic attack and traumatic hemorrhagic stroke were excluded from registration. Registration was initially performed by attending physicians at each hospital. Furthermore, to ensure complete capture of all registrations, physicians or trained research nurses visited and checked the medical charts and/or discharge summaries at referral hospitals within the study area. A stroke registration program has been coordinated mainly by the government of Iwate prefecture and the Iwate Medical Association. 15 The study was approved by our institutional ethics committee.
Data collection. Participants completed a self-report questionnaire to document their medical history including current medications and lifestyle factors such as smoking habits and alcohol intake. Baseline clinical examinations including standard 12-lead electrocardiogram were performed. BP was measured twice using an automatic digital sphygmomano meter after 5 min of rest in a sitting position, and the average of these two values was used for analysis. Blood samples were drawn from an antecubital vein, and routine hematology and biochemistry data were obtained. Serum hsCRP levels were measured using the Behring latex-enhanced CRP assay on a Behring nephelometer BN-100 (Dade Behring, Deerfield, IL). BMI was calculated by dividing weight (in kilograms) by the square of height (in meters).
Risk factor definition. According to BP levels, participants were classified into the following three groups: normotension (NT) defined as SBP < 120 mm Hg and DBP < 80 mm Hg; PreHT defined as SBP ≥120 mm Hg but <140 mm Hg or DBP ≥80 mm Hg but <90 mm Hg; hypertension (HT) defined as SBP ≥140 mm Hg, DBP ≥90 mm Hg or current use of antihypertensive agents. We further divided the PreHT group into two subcategories according to hsCRP levels (above or below median hsCRP value for each gender). DM was defined as a random blood glucose level ≥200 mg/dl, hemoglobin A 1c level ≥6.5%, or current antidiabetic therapy. The estimated glomerular filtration rate was calculated using the modified equation presented in the Japanese Modification of Diet in Renal Disease (MDRD) study. 16 Renal dysfunction was defined as an estimated glomerular filtration rate <60 ml/min/1.73 m 2 .
Statistical analysis. Data are presented as mean ± s.d. or percentage. All data were analyzed with SPSS statistical software, version 11.0 (SPSS, Chicago, IL). Comparison of continuous variables at baseline among the three BP categories of NT, PreHT, and HT was performed by one-way analysis of variance with the Scheffe's post hoc test. Furthermore, the t-test was used to compare means of continuous variables between the six subcategories of NT, PreHT, HT and with/without above median hsCRP levels according to sex. The Kruskal-Wallis analysis and Mann-Whitney U-test were used for comparisons of hsCRP levels among the three BP categories and the six subcategories, respectively. χ 2 -Test was used for comparison of categorical variables. The Kaplan-Meier method with log-rank test was used to compare ischemic stroke-free rates among the three BP categories and the six BP subcategories stratified by median hsCRP levels. A Cox proportional hazards model was constructed including these categories and adjusting for sex, baseline age (in 10-year increments), BMI, total cholesterol, high-density lipoprotein cholesterol, smoking habits, regular alcohol intake, presence of DM, atrial fibrillation (Af) and renal dysfunction. Hazard ratios (HRs) and 95% confidence intervals (CIs) for ischemic stroke were estimated from Cox models constructed using dummy variables for PreHT, HT with NT as a reference, or for the five BP subcategories with NT with below median hsCRP levels as a reference. P < 0.05 was considered to be statistically significant.
results
PreHT was found in 5,721 (25.2%) subjects (2,144 (28.0%) men and 3,577 (23.8%) women). As shown in Table 1 , there were significant differences in age, BMI, total cholesterol, high-density lipoprotein cholesterol, and hsCRP levels among the three BP categories. DM, atrial fibrillation, renal dysfunction, and current drinking were more frequent in HT subjects, whereas male gender and current smoking was more frequent among PreHT subjects.
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The median serum hsCRP level was 0.5 mg/l (95% percentile range: 0.1-4.3 mg/l) in men and 0.4 mg/l (95% percentile range: 0.1-3.4 mg/l) in women. A total of 3,281 participants (14.5%) showed hsCRP levels ≤0.1 mg/l. Participants showing hsCRP >10.0 mg/l comprised 1.4% of the study population. However, the presence of an acute infectious condition cannot be judged by CRP levels alone, so establishing a cutoff level for infection is not possible. We therefore performed analyses without any exclusion criteria for high hsCRP levels.
During the average 2.7 years of follow-up, 239 subjects (1.1%) had a first stroke. Of these, 143 (89 men and 54 women) had an ischemic stroke. The cumulative incidence of ischemic stroke was 0.2% in the NT group, 0.5% in the PreHT group, and 1.0% in the HT group. The Kaplan-Meier curves showed that the cumulative incidence of ischemic stroke was higher in the PreHT group than in the NT group (P = 0.002, Figure 1 ). However, in the multivariate Cox regression analysis, an increased HR for ischemic stroke was not significant in the PreHT group (HR = 1.72, 95% CI: 0.93-3.18) compared to the NT group after adjustment for potential confounding factors ( Table 2) .
To compare the risk of future stroke in PreHT stratified by hsCRP level, we divided the NT, PreHT, and HT groups into two subgroups according to median serum hsCRP level (0.5 mg/l in men, 0.4 mg/l in women). As shown in Table 3 , there were significant differences among the BP subgroups in sex, age, BMI, total and high-density lipoprotein cholesterol, prevalence of DM, renal dysfunction, current smoking, current drinking, and atrial fibrillation. SBP and DBP did not differ between the PreHT subgroups. As shown in Figure 2 , no significant difference in cumulative incidence of ischemic stroke was found between the NT subgroups stratified by hsCRP levels, whereas a significant difference was found between the PreHT and HT subgroups stratified by hsCRP levels (Figure 2) . Furthermore, when compared with both NT subgroups, the incidence of ischemic stroke was significantly increased in the PreHT subgroup with higher hsCRP levels, but not in the subgroup with lower hsCRP levels.
For every 1,000 subjects of the present cohort, there were 0.8 ischemic stroke events per year in the NT group, 2.0 events in the total PreHT group, 2.9 events in the PreHT subgroup with higher hsCRP levels, and 4.0 events in the HT group. Thus, the attributable risk to total PreHT was 1.2 excess events of ischemic stroke per year per 1,000 subjects, compared to 2.1 excess events per year attributed to the PreHT subgroup with higher hsCRP levels.
As shown in Table 4 , after adjustment for potential confounding factors in the Cox model, the risk of future ischemic stroke did not differ between the NT subgroups stratified by hsCRP levels. In contrast, when compared to the NT subgroup with lower hsCRP levels, the HR for ischemic stroke was significantly increased in the PreHT subgroup with higher hsCRP levels (HR = 2.63, 95% CI: 1.11-6.24), but not in the subgroup with lower hsCRP levels (HR = 0.91, 95% CI: 0.31-2.73). These findings remained the same also when compared to the total NT group (HR = 2.42, 95% CI: 1.27-4.64 in the PreHT subgroup with higher hsCRP levels). In the HT group, the HR for ischemic stroke was significantly increased in both the higher and lower hsCRP subgroups (HR = 3.47 and 2.64, P = 0.003 and 0.025, respectively) compared to the NT subgroup with lower hsCRP levels. Probability values for the interaction between hsCRP value and BP category on ischemic stroke were 0.182 in the PreHT group and 0.819 in the HT group.
discussion
In the Iwate-KENCO study, we examined the effect of lowgrade inflammation, represented by hsCRP, on the relatively short-term risk of ischemic stroke in PreHT subjects with no cardiovascular history. During the mean follow-up period of 2.7 years, the total PreHT group did not have a significantly higher risk for ischemic stroke independent of established risk factors than the total NT group. In contrast, after stratification of BP category by hsCRP levels, the PreHT subgroup with higher hsCRP levels had a significantly higher risk for ischemic stroke than the total NT group. To the best of our knowledge, this is the first prospective cohort study that has assessed the incidence of ischemic stroke among PreHT individuals stratified by hsCRP levels in the general population. Previous studies have demonstrated a relationship between PreHT and the incidence of stroke. The Framingham Heart study 17 and the ARIC study 6 reported no significant increase in the risk of ischemic stroke in the PreHT group compared to the optimal BP group (SBP <120 mm Hg and DBP <80 mm Hg). In contrast, recent Japanese studies, such as the Suita study 18 and the Japan Public Health Center-based Prospective study, 19 have shown a significant association between PreHT and the incidence of stroke. The inconsistency between Western and Japanese PreHT subjects in terms of ischemic stroke risk may be derived from differential genetic risk factors and/or dietary pattern, as suggested by a report of Japanese mortality from stroke showing this to be more than double that in the United States. 20 This study has shown no significant increase in the Data are presented as mean ± s.d. or percentage. CRP, C-reactive protein; HDL, high-density lipoprotein; HT, hypertension; NT, normotension; PreHT, prehypertension. *P < 0.05 vs. NT with lower CRP. **P < 0.05 vs. PreHT with lower CRP. ***P < 0.05 vs. HT with lower CRP.
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Prehypertension Subtype and Ischemic Stroke risk of ischemic stroke in the PreHT group compared to the NT group. This may be derived from the shorter observation period in our study compared to other studies. Several epidemiological studies have revealed that hsCRP levels were positively associated with risk of ischemic stroke in the general population. 9-11 The Women's Health Study showed that the prediction effect for the risk of vascular disease by CRP was most striking among women with low cardiovascular risk. 21 In the report from the Honolulu Heart Program, Curb et al. 22 suggested that, in the presence of other risk factors such as HT, a high risk of stroke could mask any residual effects of inflammation. In this study with a mean follow-up of 2.7 years, the risk of ischemic stroke was not significantly increased in the total PreHT group, but was increased in the PreHT subgroup with elevated hsCRP levels. These findings indicate that hsCRP is a relatively short-term marker for cerebrovascular risk in PreHT.
Although CRP-related risk stratification for ischemic stroke was shown in the PreHT group but not in the NT group, the mechanisms underlying this phenomenon are uncertain. Several possible explanations are proposed. It has been shown that PreHT is related to subclinical atherosclerosis including increased coronary atherosclerosis, 23 carotid and brachial intima-media thickness 24 and microalbuminuria. 25 Furthermore, it has been reported that elevated CRP reflects the burden of atherosclerosis [26] [27] [28] and is directly associated with the development of atherosclerosis. 29 Chrysohoou et al. revealed an association between PreHT status and inflammatory markers including CRP in a CVD-free population, and thus suggested that inflammation contributes to the atherosclerotic effects of PreHT. 30 The coexistence of PreHT and elevated hsCRP levels may therefore represent an advanced state of the atherosclerotic process and may thus be associated with an elevated risk of ischemic stroke.
How best to manage PreHT has been the subject of recent debate. The JNC-7 has identified several problems inherent in dealing with large numbers of PreHT individuals. This means that identification of those PreHT individuals at increased risk for future CVD may be warranted. The Strong Heart Study showed that, compared to individuals with NT, the HR for any cardiovascular event was approximately doubled for those with PreHT alone and was 3.7 for those with both PreHT and DM. 7 The ARIC study showed that, compared to the optimal BP group, the HR for cardiovascular events was 2.3 for the high-normal BP only group, 4.1 for the high-normal BP with DM group, and 3.6 for the group with BMI ≥30 kg/m 2 (ref. 6 ). This study showed that, when compared to the total NT group, the HR for incidence of ischemic stroke was 1.7 (P = 0.086) for the total PreHT group and 2.4 (P = 0.008) for the PreHT subgroup with elevated hsCRP levels. Our finding of excess risk of ischemic stroke associated with PreHT in conjunction with elevated hsCRP levels may therefore contribute to the development of clinical strategies for the management of PreHT. These could include the adoption of healthy lifestyles and pharmacological treatment including statin therapy, which has recently been reported to be associated with a reduction in CVD risk in subjects with elevated hsCRP levels in the JUPITER trial. 31 Our study had several limitations. The primary limitation was the relatively short observation period. Hence, it is uncertain whether the present data apply to middle or long-term risk of ischemic stroke. Second, our data are based on a single determination of hsCRP instead of two measures, as currently recommended. 32 This limitation would tend to increase the variability of our hsCRP measurements and could lead to an underestimation of its true effects. Third, our study did not assess the use of drugs that can lower hsCRP levels, such as statins. 33 However, it was unlikely that the frequency of the use of these medications was higher in event-free participants. Fourth, serum hsCRP levels recorded in our study were lower than those previously reported in community based studies in Western countries. When compared to other ethnic groups, several community based studies have demonstrated that hsCRP levels in the general Japanese population are lower 34 and the cutoff point of hsCRP for detecting individuals at high risk for coronary heart disease is also lower. 35 Therefore, the cutoff point of hsCRP for predicting ischemic stroke in our population may not be simply extrapolated to other populations. Finally, of the total number of PreHT subjects who developed ischemic stroke, none had Af in the group with lower CRP levels, while 29% had Af in the group with higher CRP levels. This difference in the frequency of Af between the PreHT subgroups was not statistically significant (P = 0.290); however, we cannot completely exclude the possibility that Af had an influence on the association between PreHT stratified by hsCRP level and the incidence of ischemic stroke.
In conclusion, in the PreHT subgroup higher hsCRP levels were associated with an elevated risk of future ischemic stroke compared to NT subjects in the general Japanese population followed up for an average of 2.7 years. HsCRP-related stratification is useful for the estimation of relatively short-term risk of ischemic stroke in PreHT subjects. 
